Alan B. Sandler Zai Lab LTD (ZLAB) insider trading activity

ZLAB Quotes by TradingView

Alan B. Sandler is Head of Global Dev., Oncology of Zai Lab Ltd. Currently has a direct ownership of 28,985 shares of ZLAB, which is worth approximately $540,860. The most recent transaction as insider was on Apr 01, 2022, when has been sold 1,060 shares (American Depositary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29K
0% 3M change
0% 12M change
Total Value Held $540,860

Alan B. Sandler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2022
BUY
Exercise of conversion of derivative security
-
1,060 Added 3.53%
28,985 American Depositary Sh...
Dec 01 2021
SELL
Payment of exercise price or tax liability
$147,802 $71.23 p/Share
2,075 Reduced 6.92%
27,925 Ordinary Shares

Also insider at

MRTX
Mirati Therapeutics, Inc. Healthcare
Chief Medical Officer
ELEV
Elevation Oncology, Inc. Healthcare
ABS

Alan B. Sandler

Head of Global Dev., Oncology
Cambridge, MA

Track Institutional and Insider Activities on ZLAB

Follow Zai Lab Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZLAB shares.

Notify only if

Insider Trading

Get notified when an Zai Lab LTD insider buys or sells ZLAB shares.

Notify only if

News

Receive news related to Zai Lab Ltd

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZLAB